Diagnosis and classification of polyarteritis nodosa

Journal of Autoimmunity

Volumn 48-49, Issue , 2014, Pages 84-89

  Hernández Rodríguez, José ^a   Alba, Marco A ^a   Prieto González, Sergio ^a   Cid, Maria C ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Classification; Polyarteritis nodosa; Treatment; Vasculitis

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE;

ABDOMINAL PAIN; ABNORMAL LABORATORY RESULT; ACUTE PHASE RESPONSE; ANEMIA; ANGIOGRAPHY; ARTERITIS; ARTHRALGIA; ARTICLE; BLOOD VESSEL BIOPSY; CENTRAL NERVOUS SYSTEM DISEASE; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; COLON ULCER; CORTICOSTEROID THERAPY; CRANIAL NERVE PARALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIARRHEA; DIGESTIVE SYSTEM ULCER; DISEASE CLASSIFICATION; DRUG PULSE THERAPY; EOSINOPHILIC GRANULOMA; ERYTHROCYTE SEDIMENTATION RATE; ESOPHAGUS ULCER; FEVER; HEART DISEASE; HEMATEMESIS; HEMATURIA; HEPATITIS B; HISTOPATHOLOGY; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LEUKOCYTOSIS; MAINTENANCE THERAPY; MELENA; MICROANEURYSM; MONONEUROPATHY MULTIPLEX; MYALGIA; NAUSEA AND VOMITING; ORCHITIS; PATHOGENESIS; PERIPHERAL NEUROPATHY; PERITONITIS; PLEURISY; POLYARTERITIS NODOSA; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; RECTUM HEMORRHAGE; REMISSION; SKIN NODULE; WEIGHT REDUCTION;

CLASSIFICATION; POLYARTERITIS NODOSA; TREATMENT; VASCULITIS;

HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERNATIONAL COOPERATION; NECROSIS; POLYARTERITIS NODOSA; SOCIETIES, MEDICAL;

EID: 84895887339     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2014.01.029     Document Type: Article

References (40)

1. Jennette J.C., Falk R.J., Bacon P.A., Basu N., Cid M.C., Ferrario F., et al. 2012 Revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 2013, 65:1-11.
2. Lie J.T. Systemic and isolated vasculitis. A rational approach to classification and pathologic diagnosis. Pathol Annu 1989, 24:25-114.
3. Hernández-Rodríguez J., Hoffman G.S. Updating single-organ vasculitis. Curr Opin Rheumatol 2012, 24:38-45.
4. Pagnoux C., Seror R., Henegar C., Mahr A., Cohen P., Le Guern V., et al. Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum 2010, 62:616-626. French Vasculitis Study Group.
5. González-Gay M.A., García-Porrúa C., Guerrero J., Rodríguez-Ledo P., Llorca J. The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill consensus conference definitions. Arthritis Rheum 2003, 49(3):388-393.
6. Selga D., Mohammad A., Sturfelt G., Segelmark M. Polyarteritis nodosa when applying the Chapel Hill nomenclature - a descriptive study on ten patients. Rheumatology (Oxford) 2006, 45(10):1276-1281.
7. Mahr A., Guillevin L., Poissonnet M., Ayme S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum 2004, 51(1):92-99.
8. Mohammad A.J., Jacobsson L.T., Mahr A.D., Sturfelt G., Segelmark M. Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg Strauss syndrome within a defined population in southern Sweden. Rheumatology (Oxford) 2007, 46(8):1329-1337.
9. Fauci A.S., Haynes B., Katz P. The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med 1978, 89:660-676.
10. Cid M.C., Grau J.M., Casademont J., Campo E., Coll-Vinent B., López-Soto A., et al. Immunohistochemical characterization of inflammatory cells and immunologic activation markers in muscle and nerve biopsy specimens from patients with systemic polyarteritis nodosa. Arthritis Rheum 1994, 37(7):1055-1061.
11. Pagnoux C., Cohen P., Guillevin L. Vasculitides secondary to infections. Clin Exp Rheumatol 2006, 24(Suppl.41):S71-S81.
12. Font C., Miró O., Pedrol E., Masanés F., Coll-Vinent B., Casademont J., et al. Polyarteritis nodosa in human immunodeficiency virus infection: report of four cases and review of the literature. Br J Rheumatol 1996, 35:796-799.
13. Corman L.C., Dolson D.J. Polyarteritis nodosa and parvovirus B19 infection. Lancet 1992, 339:491.
14. Calabrese L.H. Vasculitis and infection with the human immunodeficiency virus. Rheum Dis Clin North Am 1991, 17:131-147.
15. Lhote F., Cohen P., Guillevin L. Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome. Lupus 1998, 7(4):238-258.
16. Pagnoux C., Mahr A., Cohen P., Guillevin L. Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis. Medicine (Baltimore) 2005, 84(2):115-128.
17. Watts R., Lane S., Hanslik T., Hauser T., Hellmich B., Koldingsnes W., et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 2007, 66(2):222-227.
18. Guillevin L., Lhote F., Amouroux J., Gherardi R., Callard P., Casassus P. Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg-Strauss syndrome: indications for the classification of vasculitides of the polyarteritis Nodosa Group. Br J Rheumatol 1996, 35(10):958-964.
19. Coll-Vinent B., Cebrián M., Cid M.C., Font C., Esparza J., Juan M., et al. Dynamic pattern of endothelial cell adhesion molecule expression in muscle and perineural vessels from patients with classic polyarteritis nodosa. Arthritis Rheum 1998, 41:435-444.
20. Albert D.A., Rimon D., Silverstein M.D. The diagnosis of polyarteritis nodosa. I. A literature-based decision analysis approach. Arthritis Rheum 1988, 31(9):1117-1127.
21. Esteban M.J., Font C., Hernández-Rodríguez J., Valls-Solé J., Sanmartí R., Cardellach F., et al. Small-vessel vasculitis surrounding a spared temporal artery: clinical and pathological findings in a series of twenty-eight patients. Arthritis Rheum 2001, 44(6):1387-1395.
22. Molloy E.S., Langford C.A. Vasculitis mimics. Curr Opin Rheumatol 2008, 20:29-34.
23. Lightfoot R.W., Michel B.A., Bloch D.A., Hunder G.G., Zvaifler N.J., Mc Shane D.J., et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990, 33(8):1088-1093.
24. Henegar C., Pagnoux C., Puéchal X., Zucker J.D., Bar-Hen A., Le Guern V., et al. Aparadigm of diagnostic criteria for polyarteritis nodosa: analysis of a series of 949 patients with vasculitides. Arthritis Rheum 2008, 58:1528-1538. French Vasculitis Study Group.
25. Gayraud M., Guillevin L., le Toumelin P., Cohen P., Lhote F., Casassus P., et al. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum 2001, 44:666-675. French Vasculitis Study Group.
26. Basu N., Watts R., Bajema I., Baslund B., Bley T., Boers M., et al. EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. Ann Rheum Dis 2010, 69:1744-1750.
27. Craven A., Robson J., Ponte C., Grayson P.C., Suppiah R., Judge A., et al. ACR/EULAR-endorsed study to develop diagnostic and classification criteria for vasculitis (DCVAS). Clin Exp Nephrol 2013, 17:619-621.
28. Eleftheriou D., Dillon M.J., Tullus K., Marks S.D., Pilkington C.A., Roebuck D.J., et al. Systemic polyarteritis nodosa in the young: a single-center experience over thirty-two years. Arthritis Rheum 2013, 65:2476-2485.
29. Bourgarit A., Le Toumelin P., Pagnoux C., Cohen P., Mahr A., Le Guern V., et al. Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients. Medicine (Baltimore) 2005, 84(5):323-330.
30. Guillevin L., Pagnoux C., Seror R., Mahr A., Mouthon L., Le Toumelin P. The five-factor score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore) 2011, 90:19-27. French Vasculitis Study Group (FVSG).
31. Segelmark M., Selga The challenge of managing patients with polyarteritis nodosa. Curr Opin Rheumatol 2007, 19:33-38.
32. Collins M.P., Dyck P.J., Gronseth G.S., Guillevin L., Hadden R.D., Heuss D., et al. Peripheral Nerve Society guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary. JPeripher Nerv Syst 2010, 15:176-184. Peripheral Nerve Society.
33. García F., Pedrol E., Casademont J., Mellado B., Córdoba R., Cid M., et al. Polyarteritis nodosa confined to calf muscles. JRheumatol 1992, 19:303-305.
34. Hernández-Rodríguez J., Tan C.D., Koening C.L., Khasnis A., Rodríguez E.R., Hoffman G.S. Testicular vasculitis: findings differentiating isolated disease from systemic disease in 72 patients. Medicine (Baltimore) 2012, 91:75-85.
35. Hernández-Rodríguez J., Tan C.D., Rodríguez E.R., Hoffman G.S. Gynecologic vasculitis: an analysis of 163 patients. Medicine (Baltimore) 2009, 88:169-181.
36. Ruperto N., Ozen S., Pistorio A., Dolezalova P., Brogan P., Cabral D.A., et al. EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis, and childhood Takayasu arteritis. Ankara 2008. Part I: introduction and methods. Ann Rheum Dis 2010, 69:790-797.
37. Ozen S., Pistorio A., Iusan S.M., Bakkaloglu A., Herlin T., Brik R., et al. EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis 2010, 69:798-806. Paediatric Rheumatology International Trials Organisation (PRINTO).
38. Mukhtyar C., Guillevin L., Cid M.C., Dasgupta B., de Groot K., Gross W., et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 2009, 68:310-317. European Vasculitis Study Group.
39. Ribi C., Cohen P., Pagnoux C., Mahr A., Arène J.P., Puéchal X., et al. Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: a prospective randomized study of one hundred twenty-four patients. Arthritis Rheum 2010, 62:1186-1197. French Vasculitis Study Group.
40. Guillevin L., Cohen P., Mahr A., Arène J.P., Mouthon L., Puéchal X., et al. Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients. Arthritis Rheum 2003, 49:93-100.